AnGes Inc (AMGXF)
0.3353
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
AnGes Accounts Payable (Quarterly): 4.610M for March 31, 2024
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 4.610M |
December 31, 2023 | 3.024M |
September 30, 2023 | 2.275M |
June 30, 2023 | 3.326M |
March 31, 2023 | 7.247M |
December 31, 2022 | 4.220M |
September 30, 2022 | 4.034M |
June 30, 2022 | 11.16M |
March 31, 2022 | 4.054M |
December 31, 2021 | 6.263M |
September 30, 2021 | 5.213M |
June 30, 2021 | 11.02M |
March 31, 2021 | 7.202M |
December 31, 2020 | 4.985M |
September 30, 2020 | 2.143M |
June 30, 2020 | 1.916M |
March 31, 2020 | 1.148M |
December 31, 2019 | 1.681M |
September 30, 2019 | 1.328M |
June 30, 2019 | 0.5165M |
March 31, 2019 | 0.6378M |
December 31, 2018 | 1.023M |
September 30, 2018 | 1.522M |
June 30, 2018 | 1.676M |
March 31, 2018 | 0.3043M |
Date | Value |
---|---|
December 31, 2017 | 1.783M |
September 30, 2017 | 4.940M |
June 30, 2017 | 0.6409M |
March 31, 2017 | 2.762M |
December 31, 2016 | 3.346M |
September 30, 2016 | 1.870M |
June 30, 2016 | 3.787M |
March 31, 2016 | 3.888M |
December 31, 2015 | 2.046M |
September 30, 2015 | 3.842M |
June 30, 2015 | 3.625M |
March 31, 2015 | 1.685M |
December 31, 2014 | 1.733M |
September 30, 2014 | 2.813M |
June 30, 2014 | 2.622M |
March 31, 2014 | 0.4607M |
December 31, 2013 | 0.4018M |
September 30, 2013 | 2.360M |
June 30, 2013 | 2.449M |
March 31, 2013 | 0.9415M |
December 31, 2012 | 0.7777M |
September 30, 2012 | 2.892M |
June 30, 2012 | 2.633M |
March 31, 2012 | 1.844M |
December 31, 2011 | 0.7783M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
0.5165M
Minimum
Jun 2019
11.16M
Maximum
Jun 2022
4.368M
Average
4.044M
Median
Accounts Payable (Quarterly) Benchmarks
Takeda Pharmaceutical Co Ltd | 3.617B |
Nxera Pharma Co Ltd | 20.37M |
PeptiDream Inc | 19.91M |
Healios KK | 2.669M |
SanBio Co Ltd | -- |